Reverse dose-response study evaluating guarana as a natural nootropic alternative to caffeine for enhancing cognitive function (executive function, memory, attention, decision making) before and after maximal exercise, with applications for shift workers, emergency responders, and the general population.
This research investigates guarana (Paullinia cupana) as a natural nootropic alternative to caffeine, targeting cognitive performance before and after maximal physical exertion. The study addresses the cognitive challenges faced by emergency service professionals and shift workers, whose disrupted sleep-wake cycles can impair decision making, safety, and well-being. While caffeine is a common coping strategy, it can worsen circadian rhythms and sleep quality. Guarana, an FDA-approved natural extract rich in bioactive compounds, offers a promising alternative with potentially equal or superior cognitive benefits at lower caffeine doses. The research has particular relevance for military personnel, armed police, and other professionals who must make critical decisions following intense physical activity.
Study design:
Cognitive assessments:
Physical protocol:
Prior validation findings:
The research team has completed a prior double-blind randomised crossover study with 25 participants demonstrating guarana's cognitive benefits. The proposed study will further validate these findings through a more comprehensive dose-response design. The team offers extensive expertise in nutrition supplement, exercise, and cognitive science research, with capabilities spanning resting and exercise paradigms on cognitive and physical health. The research seeks funding for the proposed study and aims to establish a long-term research partnership to explore additional nootropic supplements.
University College London is a comprehensive public research university in central London, integrated with major NHS teaching hospitals for clinically embedded research and rapid translation. Co‑located labs, maker spaces, and pilot‑scale facilities span Bloomsbury and the expanding East London campus, offering flexible industry access and residency options. Corporate engagement teams structure sponsored research, secondees, and bespoke consortia to align capabilities with product roadmaps. Research is supported by competitive funding from UK Research and Innovation, the National Institute for Health and Care Research, the Wellcome Trust, and European programs. A dedicated technology transfer company manages IP, licensing, and spinouts, with pathways to seed investment and scale‑up partners.